BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22330139)

  • 1. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
    Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
    Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells.
    Yuvaraj S; Griffin AC; Sundaram K; Kirkwood KL; Norris JS; Reddy SV
    Mol Cancer Res; 2009 Aug; 7(8):1399-407. PubMed ID: 19671684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.
    Pandruvada SN; Yuvaraj S; Liu X; Sundaram K; Shanmugarajan S; Ries WL; Norris JS; London SD; Reddy SV
    Int J Cancer; 2010 May; 126(10):2319-29. PubMed ID: 19816883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells.
    Sundaram K; Sambandam Y; Balasubramanian S; Pillai B; Voelkel-Johnson C; Ries WL; Reddy SV
    Bone; 2015 Feb; 71():137-44. PubMed ID: 25445452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
    Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
    J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.
    Roccisana JL; Kawanabe N; Kajiya H; Koide M; Roodman GD; Reddy SV
    J Biol Chem; 2004 Mar; 279(11):10500-7. PubMed ID: 14699143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.
    Sundaram K; Mani SK; Kitatani K; Wu K; Pestell RG; Reddy SV
    J Cell Biochem; 2008 Apr; 103(6):1747-59. PubMed ID: 17891780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
    Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
    Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
    Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
    Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.
    Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ
    Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new osteoclastogenesis pathway induced by cancer cells targeting osteoclast precursor cells.
    Wada A; Tsuchiya M; Ozaki-Honda Y; Kayamori K; Sakamoto K; Yamaguchi A; Ikeda T
    Biochem Biophys Res Commun; 2019 Jan; 509(1):108-113. PubMed ID: 30578079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
    Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
    Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells.
    Sambandam Y; Sakamuri S; Balasubramanian S; Haque A
    J Cell Biochem; 2016 Jan; 117(1):118-25. PubMed ID: 26095774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
    Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
    Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.